Metformin and testosterone replacement therapy inversely associated with hormone‐associated cancers (prostate, colorectal and male breast cancers) among older White and Black men-Reference-Cited by-同舟云学术

Metformin and testosterone replacement therapy inversely associated with hormone‐associated cancers (prostate, colorectal and male breast cancers) among older White and Black men

Published:2022-08-08 Issue:6 Volume:97 Page:792-803
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clinical Endocrinology

Author:

Lopez David S.¹^ORCID,Malagaris Ioannis¹,Polychronopoulou Efstathia¹,Tsilidis Konstantinos K.²³,Milani Sadaf A.⁴,Kristen Peek M.¹,Villasante‐Tezanos Alejandro¹,Alzweri Laith⁵,Baillargeon Jacques¹,Kuo Yong‐Fang¹,Canfield Steven⁶

Affiliation:

1. Deparment of Preventive Medicine and Population Health University of Texas Medical Branch Galveston Texas USA

2. Department of Epidemiology and Biostatistics School of Public Health, Imperial College London London UK

3. Department of Hygiene and Epidemiology University of Ioannina School of Medicine Ioannina Greece

4. Division of Geriatrics and Palliative Medicine, Department of Internal Medicine University of Texas Medical Branch Galveston Texas USA

5. Division of Urology, Department of Surgery University of Texas Medical Branch Galveston Texas USA

6. Division of Urology UTHealth McGovern Medical School Houston Texas USA

Funder

National Institute on Aging

Cancer Prevention and Research Institute of Texas

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14803

Reference40 articles.

1. Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial

2. Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer

3. Repurposing metformin as anticancer drug: Randomized controlled trial in advanced prostate cancer (MANSMED)

4. Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis

5. Comprehensive Characterization of Androgen-Responsive lncRNAs Mediated Regulatory Network in Hormone-Related Cancers

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of prostate, colorectal and male breast cancers in relation with statins and testosterone replacement therapy: SEER-Medicare 2007–2015;Cancer Epidemiology;2024-10

2. Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies;Prostate Cancer and Prostatic Diseases;2024-07-16

3. Does metformin really reduce prostate cancer risk: an up-to-date comprehensive genome-wide analysis;Diabetology & Metabolic Syndrome;2024-07-12

4. Recognising the true value of testosterone therapy in health care;South African General Practitioner;2023-11

5. Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer;Familial Cancer;2023-06-21